Business
BioElectronics Drug-free Chronic Pain Therapy Observation Study Results
BioElectronics Drug-free Chronic Pain Therapy Observation Study Results.
About this update from Bioelectronics Corp.
[{"type":"text","content":"\n\n\n\nBioElectronics Drug-free Chronic Pain Therapy Observation Study Results\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBioElectronics Drug-free Chronic Pain Therapy Observation Study Results\n61% Pain Reduction & Decreases Medication Use in 86% (including opioids)\nPR Newswire\nFREDERICK, Md., March 29, 2016\n\n\n\nFREDERICK, Md., March 29, 2016 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of the drug-free over-the-counter, $30.00 ActiPatch® (www.actipatch.com) Musculoskeletal Pain Therapy medical devices, announced today the completion of a 6-month ActiPatch product observation study conducted in conjunction with its ongoing market research. \n\nThe study was conducted to measure the medical device's pain relief durability, its reduction of pain medication use, including prescription narcotic drugs, and its impact on the user's quality of life. \n\nOut of the 254 chronic pain sufferers that participated, 224 completed the full 6-month study. \n\nThe key findings:\n\n\nSide effects:  None reported \nTreatment durability: Over 90% of the participants reported continued relief averaging a 61% reduction in pain even after six months. \nImproved quality of life: 90% reported improved sleep, 89% reported greater physical activity and 71% reported their quality of life was much better to a great deal better. \nDecreased medication use:  86% reported a decrease in medication use that continued to improve over time. Most importantly, this decrease included prescription narcotic based drugs. \nDecreased adverse events from medication use: 68% were experiencing adverse side effects, of these 71% reported a reduction in adverse side effects. \nHealthcare savings: 65% spent less on pain therapies and 65% reported fewer visits to the Doctor and Pain Specialist.\nThe study has been accepted and will be presented at the British Pain Society annual scientific meeting being held from May 10-12 in Harrogate, UK https://www.britishpainsociety.org/2016-asm/. The Company will also be exhibiting at the Congress: Booth #42.\n\nAbout BioElec...